Skip to content

GlaxoSmithKline Pharma posts 11% rise in Q1 profit on steady vaccine business

The firm said consolidated profit for the quarter ended June 30 rose to 1.32 billion rupees ($16.10 million) from 1.19 billion rupees a year earlier.

Read More

​ The firm said consolidated profit for the quarter ended June 30 rose to 1.32 billion rupees ($16.10 million) from 1.19 billion rupees a year earlier. The firm said consolidated profit for the quarter ended June 30 rose to 1.32 billion rupees ($16.10 million) from 1.19 billion rupees a year earlier.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish